Antibiotic Prophylaxis for Dental Procedures After TAVR

High-Risk Cardiac Conditions Requiring Prophylaxis

The American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) guidelines recommend antibiotic prophylaxis for patients with transcatheter prosthetic valves, including those with TAVR, due to high risk of infective endocarditis (IE) 1, 2, 3
Patients with prosthetic material used for cardiac valve repair are also at high risk for IE and should receive antibiotic prophylaxis 1, 2
The American College of Cardiology recommends antibiotic prophylaxis for patients with previous IE, unrepaired cyanotic congenital heart disease, or repaired congenital heart disease with residual shunts or valvular regurgitation at or adjacent to prosthetic material 1, 2
Cardiac transplant recipients with valve regurgitation due to a structurally abnormal valve should receive antibiotic prophylaxis, according to the American College of Cardiology guidelines 1, 2

Dental Procedures Requiring Prophylaxis

The European Society of Cardiology recommends antibiotic prophylaxis for dental procedures involving manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa in high-risk patients, including those with TAVR 1, 4
The American College of Cardiology guidelines state that prophylaxis is not recommended for local anesthetic injections in non-infected tissues, treatment of superficial caries, removal of sutures, dental X-rays, placement or adjustment of removable prosthodontic or orthodontic appliances, or following shedding of deciduous teeth or trauma to lips/oral mucosa 4

Recommended Antibiotic Regimens

The European Heart Journal recommends a standard regimen of amoxicillin 2g orally 1 hour before procedure for adults and 50 mg/kg orally 1 hour before procedure for children with no allergy to penicillin 4, 5
For patients allergic to penicillin, the European Heart Journal recommends clindamycin 600mg orally 1 hour before procedure for adults and 20 mg/kg orally 1 hour before procedure for children 4, 5
The European Society of Cardiology suggests an alternative regimen of cephalexin 2g orally for adults or 50 mg/kg orally for children for patients allergic to penicillin without history of anaphylaxis, angioedema, or urticaria 4, 6

Rationale and Evidence

The American College of Cardiology states that IE has been reported to occur after TAVR at rates equal to or exceeding those associated with surgical aortic valve replacement, with a high 1-year mortality rate of 75% 1, 2
Maintenance of optimal oral health through regular professional dental care and good oral hygiene is critically important for reducing IE risk, according to the American College of Cardiology and European Society of Cardiology guidelines 1, 3, 4
Potential sources of dental sepsis should be eliminated at least 2 weeks before implantation of a prosthetic valve or other intracardiac/intravascular foreign material, as recommended by the European Society of Cardiology and European Heart Journal 4, 6

Important Considerations

The American College of Cardiology recommends that failing to provide prophylaxis for TAVR patients undergoing high-risk dental procedures should be avoided 1, 2
Neglecting the importance of regular dental care and good oral hygiene in preventing IE is a common pitfall to avoid, according to the American College of Cardiology guidelines 1, 3
Providing unnecessary prophylaxis for low-risk dental procedures or non-dental procedures in the absence of active infection should be avoided, as stated by the American College of Cardiology 3
Using fluoroquinolones or glycopeptides for prophylaxis is not recommended due to unclear efficacy and potential induction of resistance, according to the European Heart Journal 4

Antibiotic Prophylaxis for Patients with Prosthetic Heart Valves Undergoing Dental Procedures

1. Risk Assessment in Prosthetic Valve Patients

Patients with any type of prosthetic cardiac valve (mechanical, bioprosthetic, or transcatheter) experience markedly higher mortality from infective endocarditis (IE), with one‑year mortality rates approaching 75 %. (High‑quality observational data) 7
Prosthetic valve patients have a higher incidence of IE, greater mortality, and more frequent complications compared with native‑valve patients infected with the same pathogens. (Observational evidence) 8

2. Indications for Antibiotic Prophylaxis (Dental Procedures)

Prophylaxis is recommended for dental procedures that manipulate gingival tissue, manipulate the periapical region of teeth, or perforate the oral mucosa because these actions can introduce bacteremia. (Class I recommendation, strong evidence) 7
The three prosthetic valve types are equally high‑risk and therefore require the same prophylactic approach. (Consensus guideline) 9

3. Dental Procedures Not Requiring Prophylaxis

Local anesthetic injections in non‑infected tissue do not require prophylaxis. (Class III, no benefit) 10
Removal of sutures, dental radiographs (X‑rays), adjustment or placement of removable prosthodontic or orthodontic appliances, and shedding of deciduous teeth or trauma to lips/oral mucosa are not indications for prophylaxis. (Class III, no benefit) 10

4. Non‑Dental Procedures Not Requiring Prophylaxis

Transesophageal echocardiography, esophagogastroduodenoscopy, colonoscopy, and cystoscopy do not warrant antibiotic prophylaxis in prosthetic‑valve patients, even though these patients are at high IE risk. (Class III, no benefit) 11
Bronchoscopy and laryngoscopy are also exempt from prophylaxis. (Class III, no benefit) 9
The bacteremia rate from these non‑dental procedures is low (2‑5 %), and the organisms typically involved are unlikely to cause IE. (Low‑quality evidence) 7

5. Evidence Base and Guideline Consensus

No randomized controlled trials have definitively proven prophylaxis efficacy; a 2013 Cochrane review found insufficient evidence. (Low‑quality evidence) 7
Despite limited trial data, major cardiology societies (American Heart Association, American College of Cardiology, European Society of Cardiology) recommend prophylaxis for high‑risk prosthetic‑valve patients based on the severe consequences of IE and supportive observational studies. (Strong consensus, moderate evidence) 11

Antibiotic Prophylaxis for Patients with Prosthetic Heart Valves

Guideline Classification and Risk Designation

The American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology (ESC) classify all prosthetic heart valves (mechanical, bioprosthetic, and transcatheter) as high‑risk conditions that warrant antibiotic prophylaxis before high‑risk dental procedures, irrespective of valve type or anatomical location. This is a Class I guideline recommendation. 12

Duration of Prophylaxis

Current ACC/AHA and ESC guidelines advise indefinite antibiotic prophylaxis for any patient with a prosthetic valve who undergoes a high‑risk dental procedure; prophylaxis is not limited to the first six weeks after valve implantation. 12
Although transplant recipients experience the greatest risk of infective endocarditis within the first six months post‑transplant, prosthetic‑valve patients require lifelong prophylaxis, not a time‑limited course. 12

Dental Procedures Requiring Prophylaxis

Procedures that manipulate gingival tissue, the periapical region of teeth, or perforate oral mucosa (including extractions, periodontal surgery, and scaling that induces bleeding) are considered high‑risk and require prophylaxis in prosthetic‑valve patients. (Guideline‑based recommendation) 12

Dental and Non‑Dental Procedures Not Requiring Prophylaxis

Transesophageal echocardiography, esophagogastroduodenoscopy, colonoscopy, and cystoscopy are not recommended for antibiotic prophylaxis in prosthetic‑valve patients because the associated bacteremia rates are low (2–5 %) and the organisms are unlikely to cause endocarditis. 12
Routine oral activities such as tooth brushing and chewing produce transient bacteremia, but maintaining excellent oral hygiene is emphasized as the primary preventive strategy rather than prophylactic antibiotics. 12

Recommended Antibiotic Choice and Contraindications

Amoxicillin 2 g orally (30–60 min before the procedure) is the first‑line agent; clindamycin 600 mg orally is recommended for patients with documented penicillin allergy. (Guideline‑based recommendation) 12
Cephalosporins (e.g., cephalexin, cefazolin) are absolutely contraindicated in patients with a history of anaphylaxis, angioedema, or urticaria to penicillin or ampicillin. 12
Fluoroquinolones and glycopeptides should not be used for endocarditis prophylaxis because their efficacy is unclear and they may promote antimicrobial resistance. 12

Common Pitfalls to Avoid

Do not withhold prophylaxis for any high‑risk dental procedure in a prosthetic‑valve patient; omission is a documented error. 12
Do not substitute amoxicillin‑clavulanate (Augmentin) for amoxicillin as first‑line prophylaxis; amoxicillin alone is the recommended regimen. 12
Do not prescribe prophylaxis for gastrointestinal or genitourinary procedures in the absence of an active infection, as this is not supported by guideline recommendations. 12

Antibiotic Prophylaxis Recommendations for Patients with Prosthetic Heart Valves

Indications for Dental Antibiotic Prophylaxis

Patients with any type of prosthetic valve (mechanical, bioprosthetic, or transcatheter) should receive antibiotic prophylaxis only for dental procedures that manipulate gingival tissue, involve the periapical region of teeth, or perforate oral mucosa; procedures limited to the gastrointestinal, genitourinary, or respiratory tracts are not indicated. 13
High‑risk dental interventions that require prophylaxis in prosthetic‑valve patients include:
- Tooth extractions 14
- Root‑canal therapy that reaches the periapical area 13
- Sub‑gingival placement of antibiotic fibers or strips 14
- Initial placement of orthodontic bands (not brackets) 13
- Intraligamentary local‑anesthetic injections 14
- Prophylactic cleaning of teeth or implants when bleeding is expected 13

Dental Procedures That Do Not Require Prophylaxis

Local‑anesthetic injections administered through non‑infected tissue 13
Intra‑oral radiographs (X‑rays) 14
Removal of sutures after oral surgery 14
Placement or adjustment of removable prosthodontic or orthodontic appliances 13
Adjustment of orthodontic brackets 13
Natural shedding of primary (deciduous) teeth 14
Minor oral trauma causing lip or mucosal bleeding 14

Non‑Dental Procedures That Do Not Require Prophylaxis

Transesophageal echocardiography (TEE) 13
Esophagogastroduodenoscopy (EGD) 13
Colonoscopy 13
Cystoscopy 13
Bronchoscopy and laryngoscopy 14
Sigmoidoscopy 14
Trans‑nasal or endotracheal intubation 14

Guideline Evolution

The 2007 American Heart Association (AHA) guideline rescinded routine prophylaxis for gastrointestinal and genitourinary procedures that had been recommended since 1984, reflecting newer evidence that bacteremia from these procedures is low (2–5 %) and rarely involves organisms that cause endocarditis. 15

Recommended Antibiotic Regimens & Duration

Lifelong prophylaxis is advised for all prosthetic‑valve patients undergoing the high‑risk dental procedures listed above; the recommendation applies equally to mechanical, bioprosthetic, and transcatheter aortic valve replacement (TAVR) devices. 13

Peri‑operative Prophylaxis for Cardiac Surgery

For valve implantation or intracardiac device placement, a single dose of cefazolin 2 g IV (slow infusion) administered 30–60 minutes before skin incision is recommended. 16
In patients with documented β‑lactam allergy, vancomycin is an acceptable alternative. 16
Pre‑operative screening for nasal Staphylococcus aureus carriage, followed by decolonisation of identified carriers, is advised before elective cardiac surgery. 16

Evidence Base & Recommendation Strength

A 2013 Cochrane systematic review found no definitive evidence—no randomized controlled trials—to demonstrate that antibiotic prophylaxis prevents infective endocarditis in prosthetic‑valve patients; the evidence quality is therefore low. 13
Despite the limited trial data, the ACC/AHA, European Society of Cardiology (ESC), and AHA endorse prophylaxis (Class I recommendation) based on:
- The severe consequences of prosthetic‑valve endocarditis (≈ 75 % one‑year mortality) [observational] 13
- Observational studies showing higher rates of infective endocarditis among prosthetic‑valve recipients compared with native‑valve patients [13][14]
- Pathophysiological rationale that bacteremia from high‑risk dental procedures can seed prosthetic material 13

Emphasis on Oral Hygiene

All guideline societies stress that optimal oral hygiene and regular dental care are more effective than antibiotic prophylaxis for preventing prosthetic‑valve endocarditis. 13
Potential sources of dental sepsis should be eliminated at least two weeks before elective valve implantation. 16

Common Pitfalls to Avoid

Do not provide antibiotic prophylaxis for gastrointestinal or genitourinary procedures in prosthetic‑valve patients when there is no active infection. 13

Antibiotic Prophylaxis for Patients with Prosthetic Heart Valves Prior to Dental and Certain Procedures

Indications for Prophylaxis

The American Heart Association (AHA) classifies all prosthetic cardiac valves—including mechanical, bioprosthetic, and transcatheter devices—as high‑risk cardiac conditions that require lifelong antibiotic prophylaxis before dental procedures that manipulate gingival tissue, involve the periapical region of teeth, or perforate the oral mucosa (Class I recommendation) 17, 18.

Dental Procedures Requiring Prophylaxis

Procedures that manipulate gingival tissue (e.g., scaling, periodontal surgery, prophylactic cleaning when bleeding is expected) require prophylaxis 17, 18.
Procedures that involve the periapical region of teeth (e.g., tooth extractions, root‑canal therapy reaching the periapical area) require prophylaxis 17.
Procedures that perforate the oral mucosa (e.g., oral biopsies, initial suture removal, placement of orthodontic bands) require prophylaxis 17, 19.

Dental Procedures Not Requiring Prophylaxis

Routine anesthetic injections through non‑infected tissue do not require prophylaxis 17, 18.
Dental radiographs (X‑rays) do not require prophylaxis 17.
Placement or adjustment of removable prosthodontic or orthodontic appliances (including routine adjustment of orthodontic brackets) do not require prophylaxis 17, 19.
Shedding of deciduous teeth does not require prophylaxis 17, 19.
Bleeding from trauma to the lips or oral mucosa does not require prophylaxis 17, 19.

Recommended Antibiotic Regimens

Standard Regimen (No Penicillin Allergy)

Amoxicillin 2 g orally 30–60 minutes before the procedure (single pre‑procedure dose; no post‑procedure antibiotics) – recommended by the American College of Cardiology (ACC) and ESC (Class I) 18, 20.
If the pre‑procedure dose is missed, the same dose may be given up to 2 hours after the procedure provided no dose was administered earlier 17, 19.

Penicillin‑Allergy Regimen

Clindamycin 600 mg orally 30–60 minutes before the procedure – ACC/ESC recommendation (Class I) 18, 20.
Alternative: Azithromycin or clarithromycin 500 mg orally – ACC/ESC recommendation (Class I) 20.
Cephalexin 2 g orally is absolutely contraindicated in patients with a history of anaphylaxis, angioedema, or urticaria to penicillin – ACC/ESC warning (Class I) 18, 20.

Unable to Take Oral Medication

Cefazolin or ceftriaxone 1 g IV 20.
Clindamycin 600 mg IV 20.

Non‑Dental Procedures Not Requiring Prophylaxis

Gastrointestinal, genitourinary, and respiratory‑tract procedures (including endoscopy, colonoscopy, cystoscopy, bronchoscopy, laryngoscopy, transesophageal echocardiography, and transnasal or endotracheal intubation) do not require prophylaxis in prosthetic‑valve patients, despite their high‑risk status (ESC/ACC Class I) 18, 20, 21.

Duration of Prophylaxis

Prophylaxis is required for the lifetime of the prosthetic valve, not limited to the first six months after implantation (ACC/ESC recommendation) 18.

Evidence Quality and Guideline Consensus

The effectiveness of prophylaxis is classified as “unknown” (Class IIa, Level C evidence), but it is considered reasonable given the high mortality risk (≈ 75 % at one year) 17, 19.

Oral Hygiene and Preventive Measures

Maintaining optimal oral hygiene and regular professional dental care is more important than antibiotic prophylaxis for preventing infective endocarditis (AHA/ESC) 21.
Daily activities such as tooth brushing and chewing produce transient bacteremia far more frequently than dental procedures 21.

Common Pitfalls to Avoid

Do not prescribe prophylaxis for gastrointestinal or genitourinary procedures in the absence of active infection, as this is not supported by current guidelines and contributes to antimicrobial resistance 21.
Do not use cephalosporins in patients with a history of anaphylaxis, angioedema, or urticaria to penicillin 18, 20.
If the patient is already on chronic antibiotic therapy, select a different class (e.g., clindamycin) rather than increasing the current dose 21.